Niamh Chapman, Dean S Picone, Rachel E Climie, Martin G Schultz, Mark R Nelson, James E Sharman
{"title":"采血期间的血压及其对心血管绝对风险评估的意义。","authors":"Niamh Chapman, Dean S Picone, Rachel E Climie, Martin G Schultz, Mark R Nelson, James E Sharman","doi":"10.1159/000506646","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Blood collection and blood pressure (BP) measurements are routinely performed during the same consultation to assess absolute cardiovascular disease (CVD) risk. This study aimed to determine the effect of blood collection on BP and subsequent calculation of the absolute CVD risk.</p><p><strong>Methods: </strong>Forty-five participants aged 58 ± 9 years (53% male) had systolic BP (SBP) measured using clinical guideline methods (clinic SBP). Then, on a separate visit, BP was measured immediately before, during, and after blood collection. Absolute CVD risk scores were calculated (Framingham equation) using SBP from each measurement condition and compared.</p><p><strong>Results: </strong>The prevalence of low (<10%), moderate (10-15%), and high (≥15%) absolute CVD risks among the participants was 67%, 22%, and 11%, respectively, using clinic SBP. SBP values before and during blood collection were significantly higher compared to values after blood collection (130 ± 18 and 132 ± 19 vs. 126 ± 18 mm Hg; <i>p</i> = 0.010 and <i>p</i> = 0.003, respectively). However, there were no significant differences between clinic SBP (128 ± 18 mm Hg) and blood collection SBP (<i>p</i> = 0.99) or the absolute CVD risk scores (7.3 ± 6.5; 7.6 ± 5.9; 7.7 ± 6.1; and 7.1 ± 5.7%, respectively; <i>p</i> = 0.995 for all). The mean intraclass correlation (95% CI) indicated good agreement between absolute CVD risk scores calculated with clinic SBP and each blood collection SBP (0.86 [95% CI 0.74-0.92], 0.85 [95% CI 0.71-0.91], and 0.87 [95% CI 0.76-0.93], respectively; <i>p</i> < 0.001, for all).</p><p><strong>Conclusion: </strong>Absolute CVD risk calculation is not affected by use of SBP measurements recorded at the time of blood collection. Therefore, it is acceptable to collect blood and measure BP during the same consultation for absolute CVD risk assessment.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"8 1-2","pages":"40-46"},"PeriodicalIF":7.3000,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000506646","citationCount":"0","resultStr":"{\"title\":\"Blood Pressure during Blood Collection and the Implication for Absolute Cardiovascular Risk Assessment.\",\"authors\":\"Niamh Chapman, Dean S Picone, Rachel E Climie, Martin G Schultz, Mark R Nelson, James E Sharman\",\"doi\":\"10.1159/000506646\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Blood collection and blood pressure (BP) measurements are routinely performed during the same consultation to assess absolute cardiovascular disease (CVD) risk. This study aimed to determine the effect of blood collection on BP and subsequent calculation of the absolute CVD risk.</p><p><strong>Methods: </strong>Forty-five participants aged 58 ± 9 years (53% male) had systolic BP (SBP) measured using clinical guideline methods (clinic SBP). Then, on a separate visit, BP was measured immediately before, during, and after blood collection. Absolute CVD risk scores were calculated (Framingham equation) using SBP from each measurement condition and compared.</p><p><strong>Results: </strong>The prevalence of low (<10%), moderate (10-15%), and high (≥15%) absolute CVD risks among the participants was 67%, 22%, and 11%, respectively, using clinic SBP. SBP values before and during blood collection were significantly higher compared to values after blood collection (130 ± 18 and 132 ± 19 vs. 126 ± 18 mm Hg; <i>p</i> = 0.010 and <i>p</i> = 0.003, respectively). However, there were no significant differences between clinic SBP (128 ± 18 mm Hg) and blood collection SBP (<i>p</i> = 0.99) or the absolute CVD risk scores (7.3 ± 6.5; 7.6 ± 5.9; 7.7 ± 6.1; and 7.1 ± 5.7%, respectively; <i>p</i> = 0.995 for all). The mean intraclass correlation (95% CI) indicated good agreement between absolute CVD risk scores calculated with clinic SBP and each blood collection SBP (0.86 [95% CI 0.74-0.92], 0.85 [95% CI 0.71-0.91], and 0.87 [95% CI 0.76-0.93], respectively; <i>p</i> < 0.001, for all).</p><p><strong>Conclusion: </strong>Absolute CVD risk calculation is not affected by use of SBP measurements recorded at the time of blood collection. Therefore, it is acceptable to collect blood and measure BP during the same consultation for absolute CVD risk assessment.</p>\",\"PeriodicalId\":29774,\"journal\":{\"name\":\"Pulse\",\"volume\":\"8 1-2\",\"pages\":\"40-46\"},\"PeriodicalIF\":7.3000,\"publicationDate\":\"2020-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000506646\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pulse\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000506646\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/6/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000506646","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/6/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
背景:在同一会诊期间,常规进行采血和血压(BP)测量,以评估绝对心血管疾病(CVD)风险。本研究旨在确定采血对血压的影响以及随后对心血管疾病绝对风险的计算。方法:45例(58±9岁)参与者(53%男性)采用临床指南方法测量收缩压(SBP)。然后,在单独的访问中,在采血之前,期间和之后立即测量血压。使用每个测量条件下的收缩压计算绝对心血管疾病风险评分(Framingham方程)并进行比较。结果:患病率低(p = 0.010、p = 0.003)。然而,临床收缩压(128±18 mm Hg)与采血收缩压(p = 0.99)或CVD绝对危险评分(7.3±6.5;7.6±5.9;7.7±6.1;和7.1±5.7%;P = 0.995)。平均类内相关性(95% CI)表明,临床收缩压计算的绝对心血管疾病风险评分与每次采血收缩压之间的一致性良好(分别为0.86 [95% CI 0.74-0.92]、0.85 [95% CI 0.71-0.91]和0.87 [95% CI 0.76-0.93]);P < 0.001)。结论:使用采血时记录的收缩压测量值不影响CVD的绝对风险计算。因此,在同一会诊期间采集血液和测量血压以进行心血管疾病绝对风险评估是可以接受的。
Blood Pressure during Blood Collection and the Implication for Absolute Cardiovascular Risk Assessment.
Background: Blood collection and blood pressure (BP) measurements are routinely performed during the same consultation to assess absolute cardiovascular disease (CVD) risk. This study aimed to determine the effect of blood collection on BP and subsequent calculation of the absolute CVD risk.
Methods: Forty-five participants aged 58 ± 9 years (53% male) had systolic BP (SBP) measured using clinical guideline methods (clinic SBP). Then, on a separate visit, BP was measured immediately before, during, and after blood collection. Absolute CVD risk scores were calculated (Framingham equation) using SBP from each measurement condition and compared.
Results: The prevalence of low (<10%), moderate (10-15%), and high (≥15%) absolute CVD risks among the participants was 67%, 22%, and 11%, respectively, using clinic SBP. SBP values before and during blood collection were significantly higher compared to values after blood collection (130 ± 18 and 132 ± 19 vs. 126 ± 18 mm Hg; p = 0.010 and p = 0.003, respectively). However, there were no significant differences between clinic SBP (128 ± 18 mm Hg) and blood collection SBP (p = 0.99) or the absolute CVD risk scores (7.3 ± 6.5; 7.6 ± 5.9; 7.7 ± 6.1; and 7.1 ± 5.7%, respectively; p = 0.995 for all). The mean intraclass correlation (95% CI) indicated good agreement between absolute CVD risk scores calculated with clinic SBP and each blood collection SBP (0.86 [95% CI 0.74-0.92], 0.85 [95% CI 0.71-0.91], and 0.87 [95% CI 0.76-0.93], respectively; p < 0.001, for all).
Conclusion: Absolute CVD risk calculation is not affected by use of SBP measurements recorded at the time of blood collection. Therefore, it is acceptable to collect blood and measure BP during the same consultation for absolute CVD risk assessment.